{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:56:33Z","timestamp":1790200593622,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL150081"],"award-info":[{"award-number":["R01HL150081"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microbiome"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is often associated with respiratory viral infection and the need for increased medical intervention. The nasal mucosa plays a critical role in infection susceptibility and severity, with the nasal microbiome shaping mucosal immunity. This study investigated the association between the bacterial nasal microbiome and AECOPD. Participants included 41 individuals with COPD and 15 healthy non-COPD controls. Nasal microbiome composition was assessed from nasal epithelial lining fluid and compared at baseline between healthy participants and individuals with COPD, stratified by AECOPD history. COPD subjects who experienced one or more AECOPD in the year prior to enrollment were categorized as Ever AECOPD. COPD participants without a history of AECOPD in the prior year were categorized as Never AECOPD. Prospective exacerbation data were collected and used in a case\u2013control analysis to identify clinical and microbiological markers predictive of future AECOPD in COPD-diagnosed subjects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found two distinct nasal microbiome architectures with enrichment of protective taxa (healthy signature) or pathobionts (pathogenic signature). Nasal microbiome analysis demonstrated significant differences in nasal bacterial composition between COPD-diagnosed individuals with prior AECOPD (Ever AECOPD) compared to healthy controls. For COPD individuals with no prior AECOPD (Never AECOPD), we identified two underlying community structures; Cluster 1 subjects harbored a nasal microbiome significantly similar to healthy controls (healthy signature) and Cluster 2 subjects were significantly similar to the Ever AECOPD cohort (pathogenic signature). We evaluated the baseline microbiome of COPD-diagnosed participants based on the occurrence of at least one AECOPD 1-year after baseline sample collection (prospective AECOPD) and found that the nasal microbiome was associated with the occurrence of future AECOPD events. Prospective exacerbation was associated with reduced relative abundance of\n                      <jats:italic>Dolosigranulum pigrum<\/jats:italic>\n                      . Further analysis by qPCR showed that decreased\n                      <jats:italic>D. pigrum<\/jats:italic>\n                      abundance was associated with lower lung function and higher risk of future AECOPD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our data indicates that the nasal microbiome is associated with AECOPD phenotypes. Moreover, participants with decreased nasal\n                      <jats:italic>Dolosigranulum pigrum<\/jats:italic>\n                      abundance had lower lung function and a higher risk of future exacerbations. These findings suggest that\n                      <jats:italic>D. pigrum<\/jats:italic>\n                      may serve as a biomarker for AECOPD risk; however, validation of these findings in a larger multicenter cohort is needed.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40168-026-02357-1","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:47:13Z","timestamp":1773665233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dysbiosis of the nasal microbiome is associated with prospective acute exacerbation of COPD"],"prefix":"10.1186","volume":"14","author":[{"given":"Cristian","family":"Roca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb C.","family":"Hemphill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Speen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Jaspers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Wolfgang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Bradley","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"issue":"12","key":"2357_CR1","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","volume":"363","author":"JR Hurst","year":"2010","unstructured":"Hurst JR, Vestbo J, Anzueto A, Locantore N, M\u00fcllerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128\u201338.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1056\/NEJMoa0909883.","journal-title":"N Engl J Med"},{"issue":"6","key":"2357_CR2","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.jaci.2018.02.035","volume":"141","author":"LN Segal","year":"2018","unstructured":"Segal LN, Martinez FJ. Chronic obstructive pulmonary disease subpopulations and phenotyping. J Allergy Clin Immunol. 2018;141(6):01961\u20131971. https:\/\/doi.org\/10.1016\/j.jaci.2018.02.035.","journal-title":"J Allergy Clin Immunol"},{"key":"2357_CR3","doi-asserted-by":"publisher","DOI":"10.3205\/cto000071","volume":"9","author":"AG Beule","year":"2010","unstructured":"Beule AG. Physiology and pathophysiology of respiratory mucosa of the nose and the paranasal sinuses. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2010;9: Doc07.\u00a0Available from:\u00a0https:\/\/doi.org\/10.3205\/cto000071.","journal-title":"GMS Curr Top Otorhinolaryngol Head Neck Surg"},{"key":"2357_CR4","doi-asserted-by":"publisher","unstructured":"Zhang N, Van Crombruggen K, Gevaert E, Bachert C. Barrier function of the nasal mucosa in health and type-2 biased airway diseases. Allergy. 2016;71(3):295\u2013307. https:\/\/doi.org\/10.1111\/all.12809.","DOI":"10.1111\/all.12809"},{"key":"2357_CR5","doi-asserted-by":"publisher","unstructured":"Tai J, Han MS, Kwak J, Kim TH. Association Between Microbiota and Nasal Mucosal Diseases in terms of Immunity. Int J Mol Sci. 2021;22(9):4744. https:\/\/doi.org\/10.3390\/ijms22094744.","DOI":"10.3390\/ijms22094744"},{"key":"2357_CR6","doi-asserted-by":"publisher","unstructured":"Maheshwari K, Gupta R, Sharma R, Kaur A, Vashist A, Aggarwal G. Nasal microbiome dynamics: decoding the intricate nexus in the progression of respiratory and neurological diseases. Crit Rev Microbiol. 2024:1\u201316. Available from: https:\/\/doi.org\/10.1080\/1040841X.2024.2391488.","DOI":"10.1080\/1040841X.2024.2391488"},{"key":"2357_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/2152656720911605","volume":"11","author":"S Dimitri-Pinheiro","year":"2020","unstructured":"Dimitri-Pinheiro S, Soares R, Barata P. The microbiome of the nose\u2014friend or foe? Allergy Rhinol. 2020;11:215265672091160.","journal-title":"Allergy Rhinol"},{"issue":"3","key":"2357_CR8","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jaci.2018.02.020","volume":"142","author":"M Fazlollahi","year":"2018","unstructured":"Fazlollahi M, Lee TD, Andrade J, Oguntuyo K, Chun Y, Grishina G, et al. The nasal microbiome in asthma. J Allergy Clin Immunol. 2018;142(3):834-843.e2.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1016\/j.jaci.2018.02.020.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"2357_CR9","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jaci.2019.05.035","volume":"144","author":"K McCauley","year":"2019","unstructured":"McCauley K, Durack J, Valladares R, Fadrosh DW, Lin DL, Calatroni A, et al. Distinct nasal airway bacterial microbiotas differentially relate to exacerbation in pediatric patients with asthma. J Allergy Clin Immunol. 2019;144(5):1187\u201397.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1016\/j.jaci.2019.05.035.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"2357_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0564-7","volume":"6","author":"M P\u00e9rez-Losada","year":"2018","unstructured":"P\u00e9rez-Losada M, Authelet KJ, Hoptay CE, Kwak C, Crandall KA, Freishtat RJ. Pediatric asthma comprises different phenotypic clusters with unique nasal microbiotas. Microbiome. 2018;6(1):179.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1186\/s40168-018-0564-7.","journal-title":"Microbiome"},{"key":"2357_CR11","unstructured":"Patel SM, Farirai J, Patel MZ, Boiditswe S, Tawe L, Lekalake S, et al. The Journal of Infectious Diseases Alterations of the upper respiratory microbiome among children living with HIV infection in Botswana. Available from:\u00a0https:\/\/academic.oup.com\/jid\/advance-article\/doi\/10.1093\/infdis\/jiaf429\/8232740."},{"issue":"5","key":"2357_CR12","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.jaci.2020.10.009","volume":"147","author":"HHF Tang","year":"2021","unstructured":"Tang HHF, Lang A, Teo SM, Judd LM, Gangnon R, Evans MD, et al. Developmental patterns in the nasopharyngeal microbiome during infancy are associated with asthma risk. Journal of Allergy and Clinical Immunology. 2021;147(5):1683\u201391.","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"2357_CR13","doi-asserted-by":"publisher","unstructured":"Laufer AS, Metlay JP, Gent JF, Fennie KP, Kong Y, Pettigrew MM. Microbial communities of the upper respiratory tract and otitis media in children. mBio. 2011;2(1):e00245\u201310. https:\/\/doi.org\/10.1128\/mBio.00245-10.","DOI":"10.1128\/mBio.00245-10"},{"issue":"2","key":"2357_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011955","volume":"20","author":"RM Stubbendieck","year":"2024","unstructured":"Stubbendieck RM, Hurst JH, Kelly MS. Dolosigranulum pigrum: a promising nasal probiotic candidate. PLoS Pathog. 2024;20(2): e1011955.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1371\/journal.ppat.1011955.","journal-title":"PLoS Pathog"},{"issue":"12","key":"2357_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-014-0485-x","volume":"14","author":"MT Wilson","year":"2014","unstructured":"Wilson MT, Hamilos DL. The nasal and sinus microbiome in health and disease. Curr Allergy Asthma Rep. 2014;14(12):485.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1007\/s11882-014-0485-x.","journal-title":"Curr Allergy Asthma Rep"},{"key":"2357_CR16","unstructured":"Bari MR, Hiron MM, Zaman SM, Rahman MM, Ganguly KC. Microbes responsible for acute exacerbation of COPD. Mymensingh Med J. 2010;19(4):576\u201385. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20956903."},{"key":"2357_CR17","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.2147\/COPD.S413947","volume":"18","author":"KJ Rothnie","year":"2023","unstructured":"Rothnie KJ, Numbere B, Gelwicks S, Lu Y, Sharma R, Compton C, et al. Risk factors associated with a first exacerbation among patients with COPD classified as GOLD A and B in routine clinical practice in the UK. Int J Chron Obstruct Pulmon Dis. 2023;18:2673\u201385.\u00a0Available from:\u00a0https:\/\/doi.org\/10.2147\/COPD.S413947.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"8","key":"2357_CR18","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1136\/thx.2011.161117","volume":"66","author":"K de Boer","year":"2011","unstructured":"de Boer K, Vandemheen KL, Tullis E, Doucette S, Fergusson D, Freitag A, et al. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis. Thorax. 2011;66(8):680\u20135.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1136\/thx.2011.161117.","journal-title":"Thorax"},{"issue":"3","key":"2357_CR19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.15326\/jcopdf.2.3.2014.0147","volume":"2","author":"ER Narewski","year":"2015","unstructured":"Narewski ER, Kim V, Marchetti N, Jacobs MR, Criner GJ. Is Methicillin-Resistant Staphylococcus aureus colonization associated with worse outcomes in COPD hospitalizations? Chron Obstruct Pulm Dis J COPD Found. 2015;2(3):252\u20138.\u00a0Available from:\u00a0https:\/\/doi.org\/10.15326\/jcopdf.2.3.2014.0147.","journal-title":"Chron Obstruct Pulm Dis J COPD Found"},{"issue":"4","key":"2357_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003340","volume":"2003","author":"MB Loeb","year":"2003","unstructured":"Loeb MB, Main C, Eady A, Walker-Dilks C. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev. 2003;2003(4):CD003340.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1002\/14651858.CD003340.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2357_CR21","doi-asserted-by":"publisher","first-page":"L288","DOI":"10.1152\/ajplung.00476.2016","volume":"312","author":"ME Rebuli","year":"2017","unstructured":"Rebuli ME, Speen AM, Clapp PW, Jaspers I. Novel applications for a noninvasive sampling method of the nasal mucosa. Am J Physiol Lung Cell Mol Physiol. 2017;312(2):L288\u201396.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1152\/ajplung.00476.2016.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"2357_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/ntr\/ntae176","volume":"27","author":"E Hickman","year":"2024","unstructured":"Hickman E, Roca C, Zorn BT, Rebuli ME, Robinette C, Wolfgang MC. E-cigarette use, cigarette smoking, and sex are associated with nasal microbiome dysbiosis. Nicotine Tob Res. 2024;27(1):114\u2013124.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1093\/ntr\/ntae176.","journal-title":"Nicotine Tob Res"},{"key":"2357_CR23","doi-asserted-by":"publisher","unstructured":"Roca C, Mirmozaff ari Y, Martin WJ, Capps N, Sullivan KM, Thorp BD, Ferkol TW, Davis SD, Kimple A, Wolfgang MC. Advances in Sinonasal Microbiome Analysis. Ear Nose Throat J. 2025:1455613251341711. https:\/\/doi.org\/10.1177\/01455613251341711. Epub ahead of print. PMID: 40384122; PMCID: PMC12788811.","DOI":"10.1177\/01455613251341711"},{"issue":"1","key":"2357_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32709-y","volume":"13","author":"M Aziz","year":"2023","unstructured":"Aziz M, Palmer A, Iversen S, Salazar JE, Pham T, Roach K, et al. Design and validation of Dolosigranulum pigrum specific PCR primers using the bacterial core genome. Sci Rep. 2023;13(1): 6110.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1038\/s41598-023-32709-y.","journal-title":"Sci Rep"},{"key":"2357_CR25","doi-asserted-by":"crossref","unstructured":"Yan M, Pamp SJ, Fukuyama J, Hwang PH, Cho DY, Holmes S, et al. Nasal microenvironments and interspecific interactions influence nasal microbiota complexity and S. aureus carriage. Cell Host Microbe. 2013;14(6):631\u201340.","DOI":"10.1016\/j.chom.2013.11.005"},{"key":"2357_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1530178","volume":"14","author":"C Bergenfelz","year":"2024","unstructured":"Bergenfelz C, Do P, Larsson L, Ivarsson H, Malmborn K, H\u00e5kansson AP. Corynebacteria from the respiratory microbiota modulate inflammatory responses and associate with a reduced pneumococcal burden in the lungs. Front Cell Infect Microbiol. 2024;14:1530178.\u00a0Available from:\u00a0https:\/\/doi.org\/10.3389\/fcimb.2024.1530178.","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"2357_CR27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nrmicro2182","volume":"7","author":"M Otto","year":"2009","unstructured":"Otto M. Staphylococcus epidermidis--the \u201caccidental\u201d pathogen. Nat Rev Microbiol. 2009;7(8):555\u2013567.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1038\/nrmicro2182.","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"2357_CR28","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1128\/CMR.00092-13","volume":"27","author":"Y Achermann","year":"2014","unstructured":"Achermann Y, Goldstein EJC, Coenye T, Shirtliffa ME. Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Clin Microbiol Rev. 2014;27(3):419\u2013440.","journal-title":"Clin Microbiol Rev"},{"key":"2357_CR29","doi-asserted-by":"publisher","unstructured":"Pivard M, Moreau K, Vandenesch F. Staphylococcus aureus Arsenal To Conquer the Lower Respiratory Tract. mSphere. 2021;6(3):e00059\u201321. https:\/\/doi.org\/10.1128\/mSphere.00059-21.","DOI":"10.1128\/mSphere.00059-21"},{"issue":"5","key":"2357_CR30","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.chom.2015.03.008","volume":"17","author":"SM Teo","year":"2015","unstructured":"Teo SM, Mok D, Pham K, Kusel M, Serralha M, Troy N. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe. 2015;17(5):704\u2013715.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1016\/j.chom.2015.03.008.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"2357_CR31","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00245-10","volume":"2","author":"AS Laufer","year":"2011","unstructured":"Laufer AS, Metlay JP, Gent JF, Fennie KP, Kong Y, Pettigrew MM. Microbial communities of the upper respiratory tract and otitis media in children. MBio. 2011;2(1): e00245-10.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1128\/mBio.00245-10.","journal-title":"MBio"},{"key":"2357_CR32","doi-asserted-by":"publisher","unstructured":"Islam MA, Albarracin L, Melnikov V, Andrade BGN, Cuadrat RRC, Kitazawa H, et al. Dolosigranulum pigrum modulates immunity against SARS-CoV-2 in respiratory epithelial cells. Pathogens. 2021;10(6).\u00a0Available from:\u00a0https:\/\/doi.org\/10.3390\/pathogens10060634.","DOI":"10.3390\/pathogens10060634"},{"key":"2357_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.868086","volume":"13","author":"L Qu","year":"2022","unstructured":"Qu L, Cheng Q, Wang Y, Mu H, Zhang Y. COPD and gut-lung axis: how microbiota and host inflammasome influence COPD and related therapeutics. Front Microbiol. 2022;13: 868086.\u00a0Available from:\u00a0https:\/\/doi.org\/10.3389\/fmicb.2022.868086.","journal-title":"Front Microbiol"},{"issue":"1","key":"2357_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3109\/01480545.2016.1166250","volume":"40","author":"Y Panahi","year":"2017","unstructured":"Panahi Y, Ghanei M, Vahedi E, Mousavi SH, Imani S, Sahebkar A. Efficacy of probiotic supplementation on quality of life and pulmonary symptoms due to sulfur mustard exposure: a randomized double-blind placebo-controlled trial. Drug Chem Toxicol. 2017;40(1):24\u20139.\u00a0Available from:\u00a0https:\/\/doi.org\/10.3109\/01480545.2016.1166250.","journal-title":"Drug Chem Toxicol"},{"issue":"1","key":"2357_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0954422420000116","volume":"34","author":"SA Jamalkandi","year":"2021","unstructured":"Jamalkandi SA, Ahmadi A, Ahrari I, Salimian J, Karimi M, Ghanei M. Oral and nasal probiotic administration for the prevention and alleviation of allergic diseases, asthma and chronic obstructive pulmonary disease. Nutr Res Rev. 2021;34(1):1\u201316.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1017\/S0954422420000116.","journal-title":"Nutr Res Rev"},{"key":"2357_CR36","doi-asserted-by":"publisher","unstructured":"Brugger SD, Eslami SM, Pettigrew MM, Escapa IF, Henke MT, Kong Y, et al. Dolosigranulum pigrum cooperation and competition in human nasal microbiota. mSphere. 2020;5(5). Available from:\u00a0https:\/\/doi.org\/10.1128\/mSphere.00852-20.","DOI":"10.1128\/mSphere.00852-20"},{"issue":"9","key":"2357_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102978","volume":"24","author":"I De Boeck","year":"2021","unstructured":"De Boeck I, Wittouck S, Martens K, Spacova I, Cauwenberghs E, Allonsius CN, et al. The nasal mutualist Dolosigranulum pigrum AMBR11 supports homeostasis via multiple mechanisms. iScience. 2021;24(9): 102978.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1016\/j.isci.2021.102978.","journal-title":"iScience"},{"issue":"1","key":"2357_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01212-6","volume":"7","author":"MK Akmatov","year":"2017","unstructured":"Akmatov MK, Koch N, Vital M, Ahrens W, Flesch-Janys D, Fricke J, et al. Determination of nasal and oropharyngeal microbiomes in a multicenter population-based study - findings from Pretest 1 of the German National Cohort. Sci Rep. 2017;7(1): 1855.\u00a0Available from:\u00a0https:\/\/doi.org\/10.1038\/s41598-017-01212-6.","journal-title":"Sci Rep"}],"container-title":["Microbiome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40168-026-02357-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-026-02357-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-026-02357-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:02:02Z","timestamp":1776902522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40168-026-02357-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2357"],"URL":"https:\/\/doi.org\/10.1186\/s40168-026-02357-1","relation":{},"ISSN":["2049-2618"],"issn-type":[{"value":"2049-2618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the University of North Carolina at Chapel Hill Institutional Review Board (Study #20-3512), and all participants completed an IRB-approved informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}